Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Pulmonary valve agenesis is a rare congenital heart malformation characterized by a total or partial absence of the pulmonary valve leaflets associated with stenosis of the pulmonary artery orifice and aneurysmal dilatation of the pulmonary arteries. It usually occurs in association with additional cardiovascular malformations such as teralogy of fallot or ventricular septal defect, or can occur as part of a syndrome (e.g. 22q11.2 deletion syndrome). Clinical features depend on the presence of associated cardiac malformations and include pulmonary insufficiency, bronchial obstruction (secondary to compression by aneurysmally dilated pulmonary arteries), pulmonary stenosis, cyanosis, and cardiac failure.3424
Biomarker and diagnostic research for pulmonary valve agenesis has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for pulmonary valve agenesis.
172 publications have been identified in PubMed for pulmonary valve agenesis. Kisho has analyzed 91 by research type. Research spans Case Report / Case Series (54%), Review / Meta-Analysis (13%), and Epidemiology / Natural History (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 49 | 54% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 12:50 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries
12 |
13% |
Disease patterns and progression | 12 | 13% |
Clinical study results | 8 | 9% |
Laboratory research | 6 | 7% |
New treatment approaches | 2 | 2% |
Other research | 1 | 1% |
Testing and diagnosis research | 1 | 1% |
Jalali A (2026). [PMID: 41511738](https://pubmed.ncbi.nlm.nih.gov/41511738/). *Egypt Heart J*. [Case Report / Case Series]
Li Q (2026). [PMID: 41743088](https://pubmed.ncbi.nlm.nih.gov/41743088/). *Front Med (Lausanne)*. [Case Report / Case Series]
Prakash A (2026). [PMID: 42112059](https://pubmed.ncbi.nlm.nih.gov/42112059/). *Ann Pediatr Cardiol*. [Case Report / Case Series]
Bonfanti P (2026). [PMID: 42200266](https://pubmed.ncbi.nlm.nih.gov/42200266/). *G Ital Cardiol (Rome)*. [Case Report / Case Series]
Fraser CD Jr (2026). [PMID: 42091305](https://pubmed.ncbi.nlm.nih.gov/42091305/). *Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu*. [Review / Meta-Analysis]
Zhu W (2026). [PMID: 40350498](https://pubmed.ncbi.nlm.nih.gov/40350498/). *Pediatr Cardiol*. [Clinical Trial Publication]
Patterson KN (2026). [PMID: 41503034](https://pubmed.ncbi.nlm.nih.gov/41503034/). *Am J Ophthalmol Case Rep*. [Case Report / Case Series]
Gozzi A (2026). [PMID: 40080110](https://pubmed.ncbi.nlm.nih.gov/40080110/). *Pediatr Cardiol*. [Epidemiology / Natural History]
Minocha PK (2026). [PMID: 32119382](https://pubmed.ncbi.nlm.nih.gov/32119382/). *Unknown Journal*. [Case Report / Case Series]
Ngulube MM (2026). [PMID: 40198060](https://pubmed.ncbi.nlm.nih.gov/40198060/). *Unknown Journal*. [Review / Meta-Analysis]